
Intermittent Pneumatic Compression (IPC) Devices Market Report 2026
Global Outlook – By Type (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE)), By Distribution Channel (Clinics, Pharmacies, Online Channels, Other Offline Channels), By Application (Home Use, Hospital) – Market Size, Trends, Strategies, and Forecast to 2035
Intermittent Pneumatic Compression (IPC) Devices Market Overview
• Intermittent Pneumatic Compression (IPC) Devices market size has reached to $1.57 billion in 2025 • Expected to grow to $2.29 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Incidence Of Spinal Cord Injuries Fuels Expansion Of The Intermittent Pneumatic Compression (IPC) Devices Market • Market Trend: Cardinal Health Launches Next-Generation Vascular Refill–Responsive Compression Device • North America was the largest region in 2025.What Is Covered Under Intermittent Pneumatic Compression (IPC) Devices Market?
Intermittent pneumatic compression (IPC) devices are inflatable sleeves designed to prevent blood clots by applying external pressure to the legs using compressed air and a pump. They consist of cuffs that periodically inflate and deflate, promoting blood flow by compressing and releasing the affected area. It is commonly used to improve limb circulation, prevent deep vein thrombosis (DVT), and manage conditions such as lymphedema. The main types of intermittent pneumatic compression (IPC) devices are deep vein thrombosis (DVT) and pulmonary embolism (PE). Deep vein thrombosis (DVT) is a medical condition characterized by the development of blood clots within deep veins, most commonly found in the legs. These are sold through various distribution channels, including clinics, pharmacies, online channels, and other offline channels, for several applications, including home use and hospital use.
What Is The Intermittent Pneumatic Compression (IPC) Devices Market Size and Share 2026?
The intermittent pneumatic compression (ipc) devices market size has grown strongly in recent years. It will grow from $1.57 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increasing incidence of deep vein thrombosis, rising use of preventive compression therapy in hospitals, expansion of post-surgical care protocols, improvements in pneumatic compression design, growing clinical awareness of ipc benefits.What Is The Intermittent Pneumatic Compression (IPC) Devices Market Growth Forecast?
The intermittent pneumatic compression (ipc) devices market size is expected to see strong growth in the next few years. It will grow to $2.29 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing demand for home-use thrombosis prevention devices, rising adoption of connected medical compression systems, expansion of outpatient and home-based care models, growing focus on preventive vascular healthcare, increasing technological advancements in compression therapy. Major trends in the forecast period include increasing adoption of portable ipc devices, rising use of ipc for home-based dvt prevention, growing integration of smart pressure control systems, expansion of sequential compression technologies, enhanced focus on patient compliance and safety.Global Intermittent Pneumatic Compression (IPC) Devices Market Segmentation
1) By Type: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) 2) By Distribution Channel: Clinics, Pharmacies, Online Channels, Other Offline Channels 3) By Application: Home Use, Hospital Subsegments: 1) By Deep Vein Thrombosis (DVT): Portable DVT Compression Devices, Non-Portable (Stationary) DVT Compression Devices, Sequential Compression Devices for DVT 2) By Pulmonary Embolism (PE): Portable PE Compression Devices, Non-Portable (Stationary) PE Compression Devices, Sequential Compression Devices for PEWhat Is The Driver Of The Intermittent Pneumatic Compression (IPC) Devices Market?
The growing number of patients with spinal cord injuries is expected to propel the growth of the intermittent pneumatic compression (IPC) devices market going forward. A spinal cord injury is a damage to the spinal cord that results in loss of function, typically causing varying degrees of paralysis and sensory impairment below the level of the injury. The rise in robotic exoskeletons for spinal cord injuries is driven by improved mobility, as they provide powered limb movement and enable upright walking for rehabilitation. Intermittent pneumatic compression (IPC) devices are employed in spinal cord injury management to prevent deep vein thrombosis (DVT) by promoting blood circulation through sequential compression of the lower limbs. For instance, in May 2023, according to the Spinal Cord Injury Statistical Center, a US-based organization, in 2023, approximately 18,000 new spinal cord injuries were reported in the United States, up from an estimated 17,900 cases in 2022. Therefore, the growing number of patients with spinal cord injuries is driving the growth of the intermittent pneumatic compression (IPC) devices industry.Key Players In The Global Intermittent Pneumatic Compression (IPC) Devices Market
Major companies operating in the intermittent pneumatic compression (ipc) devices market are Cardinal Health Inc., Medtronic PLC, Medline Industries LP, B. Braun Melsungen AG, Getinge AB, Arjo AB, Tactile Systems Technology Inc., Encompass Group LLC, Currie Medical Specialties Inc., ManaMed Inc., Bio Compression Systems Inc., Direct Healthcare Group Ltd., Devon Medical Inc., Mego Afek A.C. Ltd., BSN medical GmbH, Compression Therapy UK Limited, Air Relax Inc., Innova Medical Group Inc., Huntleigh Healthcare Ltd., Smiths Medical International Ltd.Global Intermittent Pneumatic Compression (IPC) Devices Market Trends and Insights
Major companies operating in the intermittent pneumatic compression (IPC) devices market are focusing on technological advancement, such as intelligent vascular refill–responsive compression systems, which optimize blood-flow enhancement and stasis reduction by adjusting compression cycles based on each patient’s real-time vascular refill dynamics. Intelligent vascular refill–responsive compression systems use sensor-driven algorithms to detect refill time and personalize intermittent compression delivery, thereby improving therapeutic efficiency, increasing circulation, and enhancing VTE prevention outcomes. For instance, in November 2024, Cardinal Health, a US-based healthcare and medical products company, launched the Kendall SCD SmartFlow Compression System, the latest generation of its Kendall series. The system leverages Vascular Refill Detection (VRD) technology and a sequential, gradient, circumferential sleeve design to move more blood per hour than uniform compression, providing clinicians with a more efficient, reliable, and easy-to-use solution for preventing VTE and treating pain and swelling related to venous stasis.What Are Latest Mergers And Acquisitions In The Intermittent Pneumatic Compression (IPC) Devices Market?
In December 2024, SHS Capital, a Germany-based private equity firm specializing in investments in innovative healthcare companies, acquired a majority stake in Medizintechnik Rostock GmbH for an undisclosed amount. With this acquisition, SHS Capital aims to support MTR’s succession planning while strengthening its core medical technology business and enabling nationwide expansion to enhance patient access to homecare therapies across Germany. Medizintechnik Rostock GmbH is a Germany-based medical technology and homecare solutions provider, offers home sequential compression devices as part of its compression therapy services.Regional Outlook
North America was the largest region in the intermittent pneumatic compression (IPC) devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Intermittent Pneumatic Compression (IPC) Devices Market?
The intermittent pneumatic compression (IPC) devices market consists of sales of sequential compression devices, gradient compression devices, lymphedema pumps, custom-fit intermittent pneumatic compression (IPC) devices, air compression sleeves, and boots. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Intermittent Pneumatic Compression (IPC) Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.7 billion |
| Revenue Forecast In 2035 | $2.29 billion |
| Growth Rate | CAGR of 7.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Distribution Channel, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cardinal Health Inc., Medtronic PLC, Medline Industries LP, B. Braun Melsungen AG, Getinge AB, Arjo AB, Tactile Systems Technology Inc., Encompass Group LLC, Currie Medical Specialties Inc., ManaMed Inc., Bio Compression Systems Inc., Direct Healthcare Group Ltd., Devon Medical Inc., Mego Afek A.C. Ltd., BSN medical GmbH, Compression Therapy UK Limited, Air Relax Inc., Innova Medical Group Inc., Huntleigh Healthcare Ltd., Smiths Medical International Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
